Response to Yuce Sari et al.

Sofia Spampinato*, Lars U. Fokdal, Richard Pötter, Christine Haie-Meder, Jacob C. Lindegaard, Maximilian P. Schmid, Alina Sturdza, Ina M. Jürgenliemk-Schulz, Umesh Mahantshetty, Barbara Segedin, Kjersti Bruheim, Peter Hoskin, Bhavana Rai, Fleur Huang, Rachel Cooper, Elzbieta van der Steen-Banasik, Erik Van Limbergen, Marit Sundset, Henrike Westerveld, Remi A. NoutNina B.K. Jensen, Christian Kirisits, Kathrin Kirchheiner, Kari Tanderup

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)323-324
Number of pages2
JournalRadiotherapy and Oncology
Volume158
DOIs
Publication statusPublished - May 2021

Keywords

  • Cervical cancer
  • Clinical study
  • Dose-effect relationship
  • IGABT
  • Risk factors
  • Urinary morbidity
  • Uterine Cervical Neoplasms
  • Humans
  • Risk Factors
  • Fistula
  • Female
  • Brachytherapy
  • Cystitis

Cite this